rs397515783
Positions:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The ENST00000316623.10(FBN1):c.300C>T(p.Cys100=) variant causes a synonymous change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: not found (cov: 32)
Consequence
FBN1
ENST00000316623.10 synonymous
ENST00000316623.10 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 7.56
Genes affected
FBN1 (HGNC:3603): (fibrillin 1) This gene encodes a member of the fibrillin family of proteins. The encoded preproprotein is proteolytically processed to generate two proteins including the extracellular matrix component fibrillin-1 and the protein hormone asprosin. Fibrillin-1 is an extracellular matrix glycoprotein that serves as a structural component of calcium-binding microfibrils. These microfibrils provide force-bearing structural support in elastic and nonelastic connective tissue throughout the body. Asprosin, secreted by white adipose tissue, has been shown to regulate glucose homeostasis. Mutations in this gene are associated with Marfan syndrome and the related MASS phenotype, as well as ectopia lentis syndrome, Weill-Marchesani syndrome, Shprintzen-Goldberg syndrome and neonatal progeroid syndrome. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 15-48610774-G-A is Benign according to our data. Variant chr15-48610774-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 42323.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.300C>T | p.Cys100= | synonymous_variant | 4/66 | ENST00000316623.10 | NP_000129.3 | |
FBN1 | NM_001406716.1 | c.300C>T | p.Cys100= | synonymous_variant | 3/65 | NP_001393645.1 | ||
FBN1 | NM_001406717.1 | c.300C>T | p.Cys100= | synonymous_variant | 4/9 | NP_001393646.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.300C>T | p.Cys100= | synonymous_variant | 4/66 | 1 | NM_000138.5 | ENSP00000325527 | P1 | |
FBN1 | ENST00000559133.6 | c.300C>T | p.Cys100= | synonymous_variant, NMD_transcript_variant | 4/67 | 1 | ENSP00000453958 | |||
FBN1 | ENST00000674301.2 | c.300C>T | p.Cys100= | synonymous_variant, NMD_transcript_variant | 4/68 | ENSP00000501333 | ||||
FBN1 | ENST00000537463.6 | c.300C>T | p.Cys100= | synonymous_variant, NMD_transcript_variant | 4/31 | 5 | ENSP00000440294 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 19, 2012 | Cys100Cys in exon 3 of FBN1: This variant is not expected to have clinical signi ficance because it does not alter an amino acid residue and is not located withi n the splice consensus sequence. However, this variant is immediately adjacent to the likely pathogenic variant c.200G>T (p.Cys100Phe) listed above. Testing o f parental DNA would be needed to determine whether these FBN1 variants occur in trans (on separate copies of the gene) or in cis (same copy of the gene; c.299_ 300delinsTT, p.Cys100Phe) or occurred de novo. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at